Louis A. Matis - Concepedia

Author

Louis A. Matis

Alexion Pharmaceuticals (United States)ORCID

Also Known As

L A Matis, L Matis, L. A. Matis, L. Matis, L.A. Matis, LOUIS A. MATIS, Louis A Matis, Louis A. Matis, Louis Matis

100

Publications

7.8K

Citations

H-Index

121

Concepts

All Affiliations

Alexion Pharmaceuticals (United States)Alexion Pharma (Switzerland)National Institutes of Health National Cancer Institute May Institute

About

Louis A. Matis is an author at Alexion Pharmaceuticals (United States) specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	43	4.7K
2	Allergy	15	16	2.1K
3	Natural Sciences	2	2	211
4	Engineering	1	1	47
5	Social Sciences	1	1	95

Louis A. Matis

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
The Role of Fas in Autoimmune Diabetes Alexander V. Chervonsky, Yi Wang, F. Susan Wong, Cell	1997	500
The nature of major histocompatibility complex recognition by γδ T cells Hansjörg Schild, Nasim Mavaddat, Christa Litzenberger, Cell Histocompatibilityγδ T CellsImmune RegulationImmunologyT Cell Immunity	1994	403
Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion Antti Väkevä, Azin Agah, Scott A. Rollins, Circulation	1998	392
Correlations between T-cell specificity and the structure of the antigen receptor Pamela J. Fink, Louis A. Matis, David L. McElligott, Nature Antigen ReceptorSignal TransductionAutoimmune DiseaseMedicineT-regulatory Cell	1986	364
In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. Barbara L. Rellahan, Lisa Jones, A M Kruisbeek, The Journal of Experimental Medicine Adaptive Immune SystemT-regulatory CellImmunologySeb AdministrationT Cells	1990	359
Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv Thomas C. Thomas, Scott A. Rollins, Russell P. Rother, Molecular Immunology Single-chain FvAllergyAutoimmune DiseaseHumoral ResponseImmunology	1996	359
Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. William L. Fodor, B. L. Williams, Louis A. Matis, Proceedings of the National Academy of Sciences HistocompatibilityImmunologyBiomedical EngineeringImmunotherapyHyperacute Rejection Results	1994	348
Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass Jane C.K. Fitch, Scott A. Rollins, Louis A. Matis, Circulation	1999	284
Monoclonal antibody against an Ir gene product? Ethan A. Lerner, Louis A. Matis, Charles A. Janeway, The Journal of Experimental Medicine Immunocytochemical TechniqueGeneticsHla ImmunogeneticsImmunologyImmunodominance	1980	229
Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes. Jeffrey A. Bluestone, Randy Q. Cron, Melissa M. Cotterman, The Journal of Experimental Medicine AllergyAutoimmune DiseaseHuman T CellsT-regulatory CellHla Immunogenetics	1988	225

Page 1